Morbidity Management Case Study

2.14. Morbidity management and disability prevention
The lymphatic damage in chronic LF patient is irreversible and resulting physical, mental social suffering throughout their life (Dreyer, et al., 2002). One of the important goal of GPELF was to reduce the suffering of morbid individuals. However, the morbidity management and disability prevention activities have lagged behind in terms of both the numbers of countries implementing such programmes, and the proportion of people getting care and management (WHO, 2010).
The prime objective of morbidity management programme to provide access to basic recommended care (Mackenzie, et al., 2009) for every person with acute dermatolymphangioadenitis, lymphedema, elephantiasis, or hydrocele (surgery)
The countries those had already stop LF transmission must plan and implement a well-structured and rigorous morbidity management and disability prevention activities in their local programme to cover morbid individual, reduce their suffering, enhance their quality of life and achieve actual goal of elimination of LF (WHO,
High transmission takes place through the north Indian region and at the borderline of Nepal and Bangladesh, eastern and south western coastal areas, areas in the central Deccan region in the south and on the Andaman and Nicobar Islands. The LF distribution area for China, Japan and South Korea represent well with the past distribution before rigorous control and local elimination (WHO, 2008; Kimura & Itoh, 2011). In China, LF had been eliminated long before. However, the vector still remains active in the coastal belt. Beside this, imported LF case had been reported on rise (Zhang, et al., 2008). Under such situation, active surveillance is vital to prevent reoccurrence of the LF